OvaScience to Launch New Potential Fertility Treatment OvaPrime in 2015
January 13, 2014 at 08:58 AM EST
OvaScienceSM, (NASDAQ: OVAS ) today provided an update on its product pipeline and commercial plans, which are based on its egg precursor cell (EggPCSM) technology platform. OvaScience expects to commercialize AUGMENTSM
